Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk-Reference-Cited by-同舟云学术

Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk

Published:2017-08-29 Issue:12 Volume:141 Page:2423-2429
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Cui Yong¹,Shu Xiao-Ou¹,Li Hong-Lan²,Yang Gong¹,Wen Wanqing¹,Gao Yu-Tang²,Cai Qiuyin¹,Rothman Nathaniel³,Yin Hui-Yong⁴,Lan Qing²,Xiang Yong-Bing²^ORCID,Zheng Wei¹^ORCID

Affiliation:

1. Division of Epidemiology, Department of Medicine; Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor; Nashville TN

2. Department of Epidemiology; Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine; Shanghai China

3. Division of Epidemiology and Genetics; National Cancer Institute; Bethesda MD

4. Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Shanghai China

Funder

The US National Cancer Institute at the National Institutes Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31007/fullpdf

Reference44 articles.

1. Pancreatic adenocarcinoma;Ryan;N Engl J Med,2014

2. Cancer A-Z. 2017 http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics

3. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

4. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

5. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009;Luo;PLoS One,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma;International Journal of Molecular Sciences;2023-04-15

2. The Expressions of NF−κB, COX−2, Sp1, and c−Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival;Pathophysiology;2023-03-25

3. Construction of a metabolism-related gene prognostic model to predict survival of pancreatic cancer patients;Heliyon;2023-01

4. Association of urinary prostaglandin E2 metabolite and mortality among adults;Scientific Reports;2022-11-07

5. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis;International Journal of Cancer;2022-09-23